Vanguard Global Advisers’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.4K Hold
8,557
﹤0.01% 3256
2026
Q1
$35.8K Buy
+8,557
New +$35.7K ﹤0.01% 3142

Other funds holding SBC

Vanguard Global Advisers's SBC Position: Q2 2026 in Review

Vanguard Global Advisers held its SBC Medical Group (SBC) position steady in Q2 2026 at 8,557 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3256.

Vanguard Global Advisers first reported a position in SBC in Q1 2026 and has held it in 2 quarters since. The position peaked at $35.8K in Q1 2026. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Vanguard Global Advisers held 8,557 shares of SBC Medical Group worth $26.4K as of Q2 2026.
  • Vanguard Global Advisers left its SBC Medical Group share count unchanged in Q2 2026.
  • SBC Medical Group made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3256 holding.
  • Vanguard Global Advisers first reported a position in SBC Medical Group in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's SBC Medical Group position peaked at $35.8K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.